Page last updated: 2024-10-29

iohexol and Fibrocystic Breast Disease

iohexol has been researched along with Fibrocystic Breast Disease in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Fibrocystic Breast Disease: A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vetshev, PS1
Ternovo, SK1
Abduraimov, AB1
Arablinskiĭ, AV1
Shekhter, AI1

Other Studies

1 other study available for iohexol and Fibrocystic Breast Disease

ArticleYear
[Multispiral computed tomography in diagnosis of tumors of the mammary gland].
    Khirurgiia, 2005, Issue:2

    Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fibroadenoma; Fibroc

2005